Annex F Questionnaire (one per chemical)

Chemical name 

(as used by the POPs Review Committee (POPRC))	





Explanatory note: 

1.	This chemical is undergoing a risk management evaluation. It has
already satisfied the screening criteria set out in paragraph 4 (a) of
Article 8 of the Convention.  A risk profile has also been completed for
this chemical in accordance with paragraph 6 of Article 8 and with Annex
E to the Convention.

Introductory information

Name of the submitting Party/observer	



Contact details (name, telephone, e-mail) of the submitting
Party/observer	



Date of submission	





Additional Annex E information

(i) Production data, including quantity and location	



(ii) Uses	



(iii) Releases, such as discharges, losses and emissions	



Explanatory note:

2.	This information was requested for preparation of the risk profile in
accordance with Annex E of the Convention. The POPRC would like to
collect more information on these items. If you have additional or
updated information, kindly provide it.

A. Efficacy and efficiency of possible control measures in meeting risk
reduction goals (provide summary information and relevant references):



(i) Describe possible control measures

	



(ii) Technical feasibility	



(iii) Costs, including environmental and health costs	



Explanatory notes:

3.	If relevant, provide information on uses for which there may be no
suitable alternative or for which the analysis of socio-economic factors
justify the inclusion of an exemption when considering listing decisions
under the Convention. Detail the negative impacts on society that could
result if no exemption were permitted.

4.	 “Risk reduction goals” could refer to targets or goals to reduce
or eliminate releases from intentional production and use, unintentional
production, stockpiles, wastes, and to reduce or avoid risks associated
with long-range environment transport.

5.	Provide the costs and benefits of implementing the control measure,
including environmental and health costs and benefits.

6.	Where relevant and possible “costs” should be expressed in US
dollars per year.

B. Alternatives (products and processes) (provide summary information
and relevant references):



(i) Describe alternatives 

	



(ii) Technical feasibility	



(iii) Costs, including environmental and health costs	



(iv) Efficacy 	



(v) Risk	



(vi) Availability	



(vii) Accessibility	



Explanatory notes:

7.	Provide a brief description of the alternative product or process
and, if appropriate, the sector(s), use(s) or user(s) for which it would
be relevant. 

8.	If several alternatives could be envisaged for the chemical under
consideration, including non-chemical alternatives, provide information
under this section for each alternative.

9.	Specify for each proposed alternative whether it has actually been
implemented (and give details), whether it has only reached the trial
stage (again, with details) or whether it is just a proposal.

10.	The evaluation of the efficacy should include any information on the
performance, benefits, costs, and limitations of potential alternatives.

11.	Specify if the information provided is connected to the specific
needs and circumstances of developing countries. 

12.	The evaluation of the risk of the alternative should include any
information on whether the proposed alternative has been thoroughly
tested or evaluated in order to avoid inadvertently increasing risks to
human health and the environment. The evaluation should include any
information on potential risks associated with untested alternatives and
any increased risk over the life-cycle of the alternative, including
manufacture, distribution, use, maintenance and disposal.

13.	If the alternative has not been tried or tested, information on
projected impacts may also be useful.

14.	Information or comments on improving the availability and
accessibility of alternatives may also be useful.

C. Positive and/or negative impacts on society of implementing possible
control measures  (provide summary information and relevant references):

(i) Health, including public, environmental and occupational health

	



(ii) Agriculture, including aquaculture and forestry	



(iii) Biota (biodiversity) 	



(iv) Economic aspects	



(v) Movement towards sustainable development

	



(vi) Social costs	



Explanatory notes:

15.	Socio-economic considerations could include:

Any information on the impact (if any), costs and benefits to the local,
national and regional economy, including the manufacturing sector and
industrial and other users (e.g., capital costs and benefits associated
with the transition to the alternatives); and impacts on agriculture and
forestry;

Any information on the impact (if any) on the wider society, associated
with the transition to alternatives, including the negative and positive
impacts on public, environmental, and occupational health. Consideration
should also be given to the positive and negative impacts on the natural
environment and biodiversity. 

Information should be provided on how control measures fit within
national sustainable development strategies and plans.

D. Waste and disposal implications (in particular, obsolete stocks of
pesticides and clean-up of contaminated sites) (provide summary
information and relevant references):

(i) Technical feasibility	



(ii) Costs	



Explanatory note:

16.	Specify if the information provided is connected to the specific
needs and circumstances of developing countries.

E. Access to information and public education  (provide summary
information and relevant references):





Explanatory note:

17.	Please provide details here of access to information and public
education with respect to both control measures and alternatives.

F. Status of control and monitoring capacity (provide summary
information and relevant references):





Explanatory note:

18.	With regard to control capacity, the information required is on
legislative and institutional frameworks for the chemical under
consideration and their enforcement. With regard to monitoring capacity,
the information required is on the technical and institutional
infrastructure for the environmental monitoring and biomonitoring of the
chemical under consideration, not monitoring capacity for alternatives. 

G. Any national or regional control actions already taken, including
information on alternatives, and other relevant risk management
information:





Explanatory notes:

19.	Actions or measures taken could include prohibitions, phase-outs,
restrictions, cleanup of contaminated sites, waste disposal, economic
incentives, and other non-legally binding initiatives.

20.	Information could include details on whether these control actions
have been cost-effective in providing the desired benefits and have had
a measurable impact on reducing levels in the environment and
contributed to risk reduction.

H. Other relevant information for the risk management evaluation:





Explanatory notes:

21.	The above list of items is only indicative. Any other relevant
information for the risk management evaluation should also be provided.

I. Other information requested by the POPRC:

[Note to the Secretariat]





___________________

